ArticleKidney international reports2023

Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.

Bradley P Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.